ArticleJournal of molecular biology2025
E-FTMap: A Protein Structure Based Pharmacophore Identification Server for Guiding Fragment Expansion.
Article in Journal of molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Integrating modern computational techniques elevates binding mode identification for molecular fragments.Molecular diversity · 2026Article
- Hierarchical decoding of targeting tripeptide motif by the cytosolic iron-sulfur cluster assembly targeting complex.bioRxiv : the preprint server for biology · 2026Article
- A novel approach for enhancing the potency of kinase inhibitors using topological water networks.Journal of cheminformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In fragment-based drug design (FBDD), libraries of low molecular weight compounds are screened against a receptor. Due to their size, fragment hits typically bind with weak affinities by forming a handful of highly efficient interactions with the receptor. Such fragment hits must be expanded into more potent lead compounds in order to achieve higher binding affinities. Approaches for expanding fragments to leads include growing-the iterative expansion of the scaffold, and merging-the linking of two fragment hits. In both cases the design can be facilitated by information on the ligand binding preferences of the target protein. Here we describe a protocol for fragment expansion using E-FTMap, an automated web server that identifies important pharmacophore binding regions within a binding site of proteins using the receptor structure alone. E-FTMap distributes 119 small organic probes across a binding site, identifies energy minima in which similar probes bind, and clusters probes by their atom types to identify regions which preferably bind specific atom types. Unless a priori known, the binding site for this analysis can be identified by our FTMap server that uses only 16 probes to find binding hot spots that are generally preferable for ligand binding, whereas the subsequent use of E-FTMap provides atom-specific information. The utility of E-FTMap as a tool for guiding the expansion of fragments into higher affinity binders is demonstrated by its application to 17 proteins that have been targeted by FBDD. The E-FTMap webserver is publicly accessible at https://eftmap.bu.edu/.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.